Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant PCV chemotherapy trial in highly anaplastic oligodendroglioma
ISRCTN32891249Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- Jan 1999
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of procarbazine, lomustine and vincristine in Oligodendroglioma (OG), oligoastrocytoma and brain neoplasm (2 arms), sponsored by Medical Research Council. Primary endpoint: Overall survival. Started Jan 1999; status: completed.
02
Drugs
procarbazinelomustinevincristine
03
Conditions
Oligodendroglioma (OG)oligoastrocytomabrain neoplasm
Beyond the preview
Go deeper on ISRCTN32891249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN32891249.